(Q33486033)

27 July 2017

Phase II evaluation of VP-16-213 in patients with advanced breast cancer: a Southwest Oncology Group Study (English)

1 reference

27 July 2017

C. B. Vaughn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7237465

25 March 2024

F. Panettiere

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7237465

25 March 2024

T. Thigpen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7237465

25 March 2024

R. Bottomley

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7237465

25 March 2024

B. Hoogstraten

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7237465

25 March 2024

B. Samal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7237465

25 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7237465

25 March 2024

publication date

1 May 1981

1 reference

27 July 2017

Cancer Treatment Reports

1 reference

27 July 2017

65

1 reference

27 July 2017

443-445

1 reference

27 July 2017

5-6

1 reference

27 July 2017

Identifiers

1 reference